|
⚲
|
| Keyboard |
| Kathleen Glaub | |
|---|---|
| Firm | |
| Address | 733 Industrial Road San Carlos, CA 94070 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Curasen Therapeutics Inc | 021-524399 | Director | 5.8 M of 45.7 M |
||
| Escient Pharmaceuticals Inc | 021-465945 | Director | 60.0 M of 120.0 M |
||
| Curasen Therapeutics Inc | 021-464469 | Director | 17.6 M of 20.8 M |
||
| Curasen Therapeutics Inc | 021-420132 | Director | 18.0 M of 18.0 M |
||
| Escient Pharmaceuticals Inc | 021-374864 | Director | 38.8 M of 77.5 M |
||
| Aligos Therapeutics Inc | 021-358226 | Director | 85.0 M of 125.0 M |
||
| Codexis Inc | 021-342362 | Director | 50.0 M of 50.0 M |
||
| Curasen Therapeutics Inc | 021-331349 | Director | 27.2 M of 54.5 M |
||
| Afferent Pharmaceuticals Inc | 021-243651 | Executive Officer | 55.0 M of 55.0 M |
||